Drug Type Interferons |
Synonyms Interferon alpha-2b (Lee's Pharmaceutical), Recombinant Human Interferon α2b Gel, Yallaferon + [6] |
Target |
Action agonists, stimulants, inducers |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 2001), |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Uterine Cervicitis | China | 07 Sep 2005 | |
| Condylomata Acuminata | China | 01 Jan 2001 | |
| Herpes Genitalis | China | 01 Jan 2001 | |
| Herpes Labialis | China | 01 Jan 2001 | |
| Herpes Zoster | China | 01 Jan 2001 | |
| Uterine Diseases | China | 01 Jan 2001 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HPV16 Infection | Phase 3 | China | 01 Sep 2015 | |
| Gynecological infection | Phase 3 | - | 01 Mar 2011 | |
| Human Papillomavirus Infection | Phase 3 | - | 01 Mar 2011 |






